Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Interstellar comet 3I/ATLAS reveals weird wobbling jets in rare sun-facing tail - 2Picking Your Next SUV: 4 Brands Offering Execution, Solace, and Wellbeing
- 34 African Vacationer Locations
- 4Pfizer says patient dies after receiving hemophilia drug in trial
- 5Releasing Learning Experiences: A Survey of the \Learning Made Fun\ Instructive Application
- Mexico says a third of 130,000 missing people might be alive, fueling criticism from families
- This Is Canada's Only Province Without Any Bears
- Ukrainian drones hit all three Baltic States − did Russia redirect them?
- What's inside Mexico's Popocatépetl? Scientists obtain first 3D images of the whole volcano
- David Duchovny's new thriller has him stripping down at 65. But its chilling premise hits close to home.
- Parents who delay baby's first vaccines also likely to skip measles shots
- Miss Thailand Pageant Contestant's Veneers Fall Out During Speech on Stage
- Jill Hennessy was a '90s TV staple. Now she's in her fearless era.
- 15 Outrageous Cosplay Outfits That Will Blow You Away
